Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.

Sechter D, Troy S, Paternetti S, Boyer P.

Eur Psychiatry. 1999 Mar;14(1):41-8.

PMID:
10572324
2.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
3.

Sertraline: a review of its use in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

Drugs Aging. 2002;19(5):377-92. Review.

PMID:
12093324
4.

Spotlight on sertraline in the management of major depressive disorder in elderly patients.

Muijsers RB, Plosker GL, Noble S.

CNS Drugs. 2002;16(11):789-94. Review.

PMID:
12383038
5.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
6.

[Fluoxetine: an update of its use in major depressive disorder in adults].

Gourion D, Perrin E, Quintin P.

Encephale. 2004 Jul-Aug;30(4):392-9. Review. French.

PMID:
15597466
7.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

8.

Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?

Zarate CA, Kando JC, Tohen M, Weiss MK, Cole JO.

J Clin Psychiatry. 1996 Feb;57(2):67-71. Review.

PMID:
8591971
9.

Fluoxetine tenth anniversary update: the progress continues.

Stokes PE, Holtz A.

Clin Ther. 1997 Sep-Oct;19(5):1135-250. Review.

PMID:
9385500
10.
11.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006117. doi: http://dx.doi.org/10.1002/14651858.CD006117. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD006117.

PMID:
20091586
12.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117. doi: 10.1002/14651858.CD006117.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD006117.

PMID:
19370626
13.

Care of depressed patients with anxiety symptoms.

Nutt DJ.

J Clin Psychiatry. 1999;60 Suppl 17:23-7; discussion 46-8. Review.

14.

Fluoxetine. A pharmacoeconomic review of its use in depression.

Wilde MI, Benfield P.

Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61. Review.

PMID:
10180753
15.

Use of serotonin selective reuptake inhibitors in geriatric depression.

Newhouse PA.

J Clin Psychiatry. 1996;57 Suppl 5:12-22. Review.

PMID:
8647788
16.

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E.

J Sex Marital Ther. 1997 Fall;23(3):176-94. Review.

PMID:
9292833
17.
18.

Sertraline. A pharmacoeconomic evaluation of its use in depression.

Davis R, Wilde MI.

Pharmacoeconomics. 1996 Oct;10(4):409-31. Review.

PMID:
10184609
19.

An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.

Sheehan DV, Kamijima K.

Int Clin Psychopharmacol. 2009 Mar;24(2):43-60. Review.

PMID:
21456103
20.

Supplemental Content

Support Center